PACS Q4 2025 Earnings Summary
Overall summary: PACS delivered record Q4 and FY25 results with strong revenue growth, rising mature-facility occupancy, and improving quality metrics, supported by a robust locally led, centrally supported operating model. The company emphasized disciplined capital allocation, maintained very low leverage, and executed targeted acquisitions while selectively increasing real estate ownership. Management’s outlook for 2026 is confident, focused on continued integration, clinical excellence, leadership development, and disciplined M&A amid favorable demographic and consolidation trends.
Growth
- FY25 revenue up ~29% to $5.29B; Q4 revenue up ~12% to $1.36B
- Portfolio scaled to 321 facilities across 17 states; 35,379 total operating beds (32,854 skilled nursing; 2,525 assisted living)
- Mature-facility occupancy increased to 94.9% (up 50 bps y/y)
- 73.4% of skilled nursing facilities rated 4–5 stars in CMS quality measures; mature average QM rating improved to 4.4 from 4.3
Business development
- Completed 8 strategic acquisitions in 2025 within existing markets
- Announced January 2026 acquisition of 3 facilities (2 in Alaska with real estate; 1 in Idaho)
- Eight de novo projects since inception; Oceanside, CA new build achieved deficiency-free initial survey and reached profitability within first year
- Selective increase in real estate ownership to strengthen long-term alignment
Financials
- Q4 2025: revenue $1.36B (+~12% y/y), net income $59.8M, adjusted EBITDAR $237.7M, adjusted EBITDA $142.1M
- FY 2025: revenue $5.29B (+~29% y/y), net income $191.5M, diluted EPS $1.22, adjusted EBITDAR $883.9M, adjusted EBITDA $505.0M
- Portfolio occupancy averaged 89.1% for FY25; ramping facilities at 86.3% (y/y decline due to cohort mix); mature facilities at 94.9%
Capital & funding
- Ended FY25 with net leverage of ~0.3x, supporting durability and flexibility
- Disciplined capital allocation focused on optimizing 2024 acquisitions and selective real estate purchases
- Willingness to invest ahead of revenue for de novos (e.g., Oceanside pre-opening investments)
Operations & strategy
- Locally led, centrally supported model with centralized services (accounting, compliance, HR, IT, regulatory)
- 2025 focused on integration and performance of 2024 acquisitions, driving clinical and occupancy improvements
- Administrator-in-Training program with 38 participants to deepen leadership bench and support growth
- Strengthened infrastructure, systems and compliance to support scale as a public company
- Seven zero-deficiency surveys in 2025; continued improvements in falls, pressure ulcers, medication management and discharge outcomes in highlighted facilities
Market & outlook
- Demographic tailwinds and fragmented industry support continued consolidation opportunity
- 2026 priorities: integrate and optimize portfolio, invest in people and clinical capabilities, and pursue disciplined M&A with selective real estate ownership
- Management expects continued steady reporting cadence and consistent execution
Risks & headwinds
- Regulatory and compliance complexity in skilled nursing (e.g., survey rigor in states like California)
- Ongoing integration and stabilization of recently acquired facilities; cohort mix effects on ramping occupancy
- Exposure to hospital discharge patterns and rising patient acuity requirements
Sentiment: positive
